Clinical Commissioning Policies
This page lists the Clinical Commissioning Policies – known locally as Lavender Statements – that have been adopted by OCCG’s Board. NHS organisations caring for Oxfordshire patients must take account of these statements when considering treatment or referral to other specialists.
284a Adhesive Capsulitis (Frozen Shoulder)
286a Foetal Alcohol Spectrum Disorders
287c Arthroscopic Knee Surgery for Meniscal Tears
288 Continuous Subcutaneous Insulin Infusion (Insulin Pumps) for Adults with type 1 Diabetes
289a Continuous Glucose Monitors
290a TVPC 68 Female sterilisation
291 Myelodysplastic Syndrome
293a Prescribing of Cannabis-based Products for Medicinal Use
294 Corticosteroid Injections for Pre-patellar and Olecranon Bursitis
295a Hearing Aids for Hearing Loss in Adults
296c Policy update primary hip and knee replacement
297 TVPC89 Real-time Continuous Glucose Monitors for Paediatric Patients with Type 1 Diabetes
298 TVPC90 Lidocaine infusions
299 Negative Pressure Wound Therapy Policy
300 Reconstructive Breast Surgery Post Cancer